Show simple item record

dc.contributor.authorKhattak, Hajra
dc.contributor.authorGallos, Ioannis
dc.contributor.authorCoomarasamy, Arri
dc.contributor.authorTopping, A E
dc.date.accessioned2024-10-08T11:43:28Z
dc.date.available2024-10-08T11:43:28Z
dc.date.issued2022-04-13
dc.identifier.citationKhattak H, Gallos I, Coomarasamy A, Topping AE. Why are women considering ovarian tissue cryopreservation to preserve reproductive and hormonal ovarian function? A qualitative study protocol. BMJ Open. 2022 Apr 13;12(4):e051288. doi: 10.1136/bmjopen-2021-051288en_US
dc.identifier.eissn2044-6055
dc.identifier.doi10.1136/bmjopen-2021-051288
dc.identifier.pmid35418423
dc.identifier.urihttp://hdl.handle.net/20.500.14200/6063
dc.description.abstractIntroduction: Current fertility preservation options available to women are oocyte cryopreservation (egg freezing) or embryo cryopreservation. A newer procedure, ovarian tissue cryopreservation (OTC), has become available in some centres, which offers another option for women and girls considering fertility preservation. These procedures are commonly offered to women about to undergo treatments for cancer. OTC involves removing sections of ovarian tissue and cryopreserving it for future reimplantation, often several years later. OTC offers girls and women who may become infertile with optionality and the possibility of pregnancy. OTC has potential for other applications, including restoring ovarian endocrine function beyond biological menopause. This is not without controversy but has led to some women considering undergoing the procedure for purposes of ovarian hormonal preservation (conservation of ovarian endocrine function). OTC is invasive, involves two surgical procedures with concomitant risks and can be costly. Understanding why women may consider and ultimately undergo OTC is timely, so that evidence-based and women-centred care can be provided. Methods: A pragmatic narrative qualitative design will be used. A purposive sample of women aged 18-45 who are considering, or have sought, OTC will be recruited over 1-year period. Potential participants will be approached via a clinic that offers OTC on a private basis or via social media. Analysis: Participant interviews will be audio and, if consented, video recorded. These will be conducted face-to-face or virtually. The recordings will be transcribed verbatim and analysed using a thematic analysis approach supported by NVivo software. Ethics and dissemination: Ethical approval has been granted by the Institutional Ethical Review ERN_19-1578A. We expect to disseminate the findings of this study through journal articles, conference presentations and multimedia to public.en_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.urlhttp://bmjopen.bmj.com/en_US
dc.rights© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
dc.subjectGynaecologyen_US
dc.titleWhy are women considering ovarian tissue cryopreservation to preserve reproductive and hormonal ovarian function? A qualitative study protocol.en_US
dc.typeArticleen_US
dc.typeOtheren_US
dc.source.journaltitleBMJ Openen_US
dc.source.volume12
dc.source.issue4
dc.source.beginpagee051288
dc.source.endpage
dc.source.countryEngland
rioxxterms.versionNAen_US
dc.contributor.trustauthorTopping, Anne
dc.contributor.departmentNursingen_US
dc.contributor.roleNursing and Midwifery Registereden_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record